Avenio
PrivateLast Round
Seed
Sep 18, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Avenio is a healthcare technology company that provides an AI-powered clinical protocol platform for biopharma, biotech, and contract research organizations.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avenio Comparables
Compare Avenio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trially AI | 89% | |
| BEKhealth | 86% | |
| Dyania Health | 84% | |
Avenio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 18, 2025 |
Key People
Founding team and executive leadership
Avenio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nvidia Inception | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors increased 129% MoM.
- Oct 15, 2025
Grew 20% QoQ, from 15 to 18 employees.
Avenio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avenio's valuation, stock price, and market status.